| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.00036 | 1 |